Abstract
A long-term study of gonadal function was conducted in 46 men and 28 women in prolonged remission of advanced Hodgkin's disease after cyclical combination chemotherapy with nitrogen mustard, vinblastine, prednisolone, and procarbazine. The mean follow-up was 6.9 years. Azoospermia or profound oligospermia occurred in 36 of the men, but late recovery was occasionally observed. Testosterone secretion was preserved. Amenorrhoea and gonadal hormone deficiency developed in 22 of the women and never recovered. Partial or complete chemical sterilisation and gonadal hormone deficiency is currently a consequence of cure of advanced Hodgkin's disease in most patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chapman R. M., Sutcliffe S. B., Malpas J. S. Cytotoxic-induced ovarian failure in Hodgkin's disease. II. Effects on sexual function. JAMA. 1979 Oct 26;242(17):1882–1884. [PubMed] [Google Scholar]
- Chapman R. M., Sutcliffe S. B., Malpas J. S. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA. 1979 Oct 26;242(17):1877–1881. [PubMed] [Google Scholar]
- Chapman R. M., Sutcliffe S. B., Malpas J. S. Male gonadal dysfunction in Hodgkin's disease. A prospective study. JAMA. 1981 Apr 3;245(13):1323–1328. [PubMed] [Google Scholar]
- Chapman R. M., Sutcliffe S. B. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood. 1981 Oct;58(4):849–851. [PubMed] [Google Scholar]
- Chapman R. M., Sutcliffe S. B., Rees L. H., Edwards C. R., Malpas J. S. Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet. 1979 Feb 10;1(8111):285–289. doi: 10.1016/s0140-6736(79)90701-3. [DOI] [PubMed] [Google Scholar]
- Fattah D. I., Chard T. Simplified method for measuring sex-hormone binding globulin. Clin Chem. 1981 Jul;27(7):1277–1279. [PubMed] [Google Scholar]
- Horning S. J., Hoppe R. T., Kaplan H. S., Rosenberg S. A. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med. 1981 Jun 4;304(23):1377–1382. doi: 10.1056/NEJM198106043042301. [DOI] [PubMed] [Google Scholar]
- LOUIS J., LIMARZI L. R., BEST W. R. Treatment of chronic granulocytic leukemia with myleran. AMA Arch Intern Med. 1956 Mar;97(3):299–308. doi: 10.1001/archinte.1956.00250210045003. [DOI] [PubMed] [Google Scholar]
- Stevenson J. C., Whitehead M. I. Postmenopausal osteoporosis. 1982 Aug 28-Sep 4Br Med J (Clin Res Ed) 285(6342):585–588. doi: 10.1136/bmj.285.6342.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutcliffe S. B., Wrigley P. F., Peto J., Lister T. A., Stansfeld A. G., Whitehouse J. M., Crowther D., Malpas J. S. MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J. 1978 Mar 18;1(6114):679–683. doi: 10.1136/bmj.1.6114.679. [DOI] [PMC free article] [PubMed] [Google Scholar]